Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines
2011 · BMC Gastroenterology · 296 citations
https://doi.org/10.1186/1471-230x-11-71
B
Beibei Zhai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
113
Papers
700
Citations
14
h-index
15
i10-index
Beibei Zhai is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: PARP inhibition in cancer therapy & Histone Deacetylase Inhibitors Research & Protein Degradation and Inhibitors. The author has an h-index of 14, co-authored 97 publications.
ORCID: 0009-0001-6303-6313Papers by this author
worksOncofetal Chondroitin Sulfate Is a Highly Expressed Therapeutic Target in Non-Small Cell Lung Cancer
2021 · Cancers · 17 citations
https://doi.org/10.3390/cancers13174489
Dianhydrogalactitol synergizes with topoisomerase poisons to overcome DNA repair activity in tumor cells
2020 · Cell Death and Disease · 7 citations
https://doi.org/10.1038/s41419-020-02780-8
Transient CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors
2024 · EMBO Molecular Medicine · 7 citations
https://doi.org/10.1038/s44321-024-00153-8
Identification of adipose tissue‐derived exosomal micro <scp>RNA</scp> as a novel causal biomarker for cognitive impairment in type 2 diabetes mellitus: Triangulating evidence from Mendelian randomization and multicentre population studies
2024 · Diabetes Obesity and Metabolism · 6 citations
https://doi.org/10.1111/dom.16121
Supplementary Figure S2 from A bi-functional PARP-HDAC inhibitor with activity in Ewing sarcoma
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27032122
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat